RBC Capital analyst Conor McNamara maintained a Hold rating on Hologic (HOLX – Research Report) on December 8 and set a price target of $89.00.

Figure 1: Expression of Gdf11 in mouse embryos. Figure 2: Construction of Gdf11 –/– mice by homologous targeting.

Capricor Therapeutics raised $86.3 million in a public offering, ensuring sufficient cash runway to fund operations into 2027 ...

We know you’ve got a lot to do. Every day delivers a new challenge. Well, those challenges are about to get easier with Windows 11.